Volume 28 Issue 6
Jun.  2015
Turn off MathJax
Article Contents

LAI Yu Ji, LIU Er Yong, WANG Li Ming, Jamie P MORANO, WANG Ning, Kaveh KHOSHNOOD, ZHOU Lin, CHENG Shi Ming. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China[J]. Biomedical and Environmental Sciences, 2015, 28(6): 421-428. doi: 10.3967/bes2015.059
Citation: LAI Yu Ji, LIU Er Yong, WANG Li Ming, Jamie P MORANO, WANG Ning, Kaveh KHOSHNOOD, ZHOU Lin, CHENG Shi Ming. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China[J]. Biomedical and Environmental Sciences, 2015, 28(6): 421-428. doi: 10.3967/bes2015.059

Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China

doi: 10.3967/bes2015.059
Funds:  This research was supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria(CHN-S10-G14-T)%Multidisciplinary HIV and TB Implementation Sciences Training(ICOHRTA2)
  • Objective To investigate the risk factors attributable to tuberculosis-related deaths in areas with human immunodeficiency virus (HIV) infection epidemics.
    Methods A prospective cohort study of newly registered patients in tuberculosis (TB) dispensaries in six representative Chinese provinces was conducted from September 1, 2009 to August 31, 2011. Risk factors for TB-associated death were identified through logistic regression analysis.
    Results Of 19,103 newly registered pulmonary TB patients, 925 (4.8%) were found to be HIV-positive. Miliary TB and acid-fast bacillus smear-negative TB were more common among these patients. Out of a total of 322 (1.7%) deaths that occurred during TB treatment, 85 (26%) of the patients were co-infected with HIV. Multivariate analysis revealed that HIV infection was the strongest predictor of death [adjusted odds ratio (aOR) 7.86]. Other significant mortality risk factors included presentation with miliary TB (aOR 4.10; 95% confidence interval: 2.14-7.88), ≥35 years of age (aOR 3.04), non-Han ethnicity (aOR 1.67), and farming as an occupation (aOR 1.59). For patients with TB/HIV co-infection, miliary TB was the strongest risk factor for death (aOR 5.48). A low CD4 count (≤200 cells/μL) (aOR 3.27) at the time of TB treatment initiation and a lack of antiretroviral therapy (ART) administration (aOR 3.78) were also correlated with an increased risk of death.
    Conclusion Infection with HIV was independently associated with increased mortality during TB treatment. Offering HIV testing at the time of diagnosis with TB, early TB diagnosis among HIV/acquired immunodeficiency syndrome patients, and the timely provision of ART were identified as the key approaches that could reduce the number of HIV-associated TB deaths.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1227) PDF downloads(44) Cited by()

Proportional views
Related

Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China

doi: 10.3967/bes2015.059
Funds:  This research was supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria(CHN-S10-G14-T)%Multidisciplinary HIV and TB Implementation Sciences Training(ICOHRTA2)

Abstract: Objective To investigate the risk factors attributable to tuberculosis-related deaths in areas with human immunodeficiency virus (HIV) infection epidemics.
Methods A prospective cohort study of newly registered patients in tuberculosis (TB) dispensaries in six representative Chinese provinces was conducted from September 1, 2009 to August 31, 2011. Risk factors for TB-associated death were identified through logistic regression analysis.
Results Of 19,103 newly registered pulmonary TB patients, 925 (4.8%) were found to be HIV-positive. Miliary TB and acid-fast bacillus smear-negative TB were more common among these patients. Out of a total of 322 (1.7%) deaths that occurred during TB treatment, 85 (26%) of the patients were co-infected with HIV. Multivariate analysis revealed that HIV infection was the strongest predictor of death [adjusted odds ratio (aOR) 7.86]. Other significant mortality risk factors included presentation with miliary TB (aOR 4.10; 95% confidence interval: 2.14-7.88), ≥35 years of age (aOR 3.04), non-Han ethnicity (aOR 1.67), and farming as an occupation (aOR 1.59). For patients with TB/HIV co-infection, miliary TB was the strongest risk factor for death (aOR 5.48). A low CD4 count (≤200 cells/μL) (aOR 3.27) at the time of TB treatment initiation and a lack of antiretroviral therapy (ART) administration (aOR 3.78) were also correlated with an increased risk of death.
Conclusion Infection with HIV was independently associated with increased mortality during TB treatment. Offering HIV testing at the time of diagnosis with TB, early TB diagnosis among HIV/acquired immunodeficiency syndrome patients, and the timely provision of ART were identified as the key approaches that could reduce the number of HIV-associated TB deaths.

LAI Yu Ji, LIU Er Yong, WANG Li Ming, Jamie P MORANO, WANG Ning, Kaveh KHOSHNOOD, ZHOU Lin, CHENG Shi Ming. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China[J]. Biomedical and Environmental Sciences, 2015, 28(6): 421-428. doi: 10.3967/bes2015.059
Citation: LAI Yu Ji, LIU Er Yong, WANG Li Ming, Jamie P MORANO, WANG Ning, Kaveh KHOSHNOOD, ZHOU Lin, CHENG Shi Ming. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China[J]. Biomedical and Environmental Sciences, 2015, 28(6): 421-428. doi: 10.3967/bes2015.059

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return